Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Modified Process Hepatitis B Vaccine

Hepatitis B vaccine (recombinant) · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Modified Process Hepatitis B Vaccine, covering 2009-03-31 to 2009-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED) [Phase 3]

See pricing